Kenneth Maiese

Background

Maiese, Kenneth was born on December 5, 1958 in Audubon, New Jersey, United States. Son of Charles and Margaret (Fioretti) Maiese.

Education

Bachelor summa cum laude, University of Pennsylvania, 1981.

Doctor of Medicine, Cornell University, 1985.

Harvard T. H. Chan School of Public Health.

Kellogg School of Management – Northwestern University.

Career

Kenneth is an internationally recognized physician-scientist whose investigations are designed to translate basic science into successful therapeutic treatments. He maintains therapeutic and scientific expertise in multiple medical disciplines, drug development, regulatory policy, and drug commercialization. He has extensive experience in academic medicine, healthcare delivery, business development, managed care, the pharmaceutical industry, and biotechnology as Member and Advisor for the National Heart, Lung, and Blood Institute Network for Biotech and Venture Capital Development, Chief Medical Officer, Professor and Chairman of Neurology and Neurosciences of Rutgers University, Global Head of Translational Medicine and External Innovation, Board Member of the Cancer Institute of New Jersey, steering committee for the Foundation for the National Institutes of Health, and advisory member for the National Institutes of Health and Howard Hughes Medical Institute.

Intern, Cornell-New York Hospital; Resident in Neurology, Cornell-New York Hospital. Assistant attending physician, Cornell-New York Hospital, 1989-1994;Assistant Professor, Cornell University Medical College, New York City, 1989-1994; Associate Professor (tenured), Departments of Neurology, Anatomy and Cell Biology, Wayne State University Center for Molecular Toxicology & Medicine, Detroit, since 1994; Director Laboratory Molecular and Cellular Cerebral Ischemia, Wayne State University Center for Molecular Toxicology, Detroit, since 1994; Professor (tenured), Wayne State University Center for Molecular Toxicology, Detroit, since 1999. Director neurological diagnosis New York Hospital, 1991-1994. Physician in Chief and Chief of Services, Rutgers University, 2010-

Professor and Chairman (tenured), Neurology and Neurosciences, Rutgers University, 2010- Adv Board of Directors, Robert Wood Johnson, New Jersey Cancer Institute, 2010-. Head Translational Medicine and Head External Innovation, Mitsubishi, 2012-. Steering Committee, National Institutes of Health Biomarkers Consortium, 2013-

Biotech and Venture Capital Innovation, National Heart, Lung, and Blood Institute, NIH, 2016-. Chief Medical Officer, Head of Clinical and Population Strategies, Altarum, 2016-. Board Member and Director, Vibrant Emotional Health-Mental Health Association, New York City, 2017-. Member and Advisor for Biotech and Venture Capital Innovation Mentor Network, National Heart, Lung, and Blood Institute, NIH, 2017-. Member and Advisor, Centers for Medicare and Medicaid Accredited Health Organizations, 2017-

Achievements

• Achievements include research in imidazole receptors, cerebral ischemia, cytokines, inflammation, growth factor neuroprotection, signal cellular transduction mechanisms, metabotropic glutamate receptors, gene regulation, gene therapy, cell longevity, oxidative stress, vascular biology, neurodegeneration, oncology, diabetes, epigenetics, and cell injury pathways with apoptosis and autophagy.
  
  Early in his career, Dr. Maiese has received outstanding investigator awards, was named a Johnson & Johnson Distinguished Investigator, Joseph Collins scholar, 1981-1985, Grupe Foundation scholar, 1985, Grantee National Institutes of Health, 1990- , National Stroke Association, 1992-1994, Alzheimer's Association, 1994-, American Heart Association, 1995-, United Cerebral Palsy Foundation, 1995-, Janssen Foundation, 1995-. Recipient Young Scientist award Journal of Cerebral Blood Flow, 1991, Hoechst Investigator award, 1993, Robert G. Siekert award instroke, 1994, Maiese Laboratory Neurosci. Training award J & J/Janssen, 1998-, and Bugher Foundation Award, 2005-.
  
  He also was chosen as a Henrietta B. and Frederick H. Bugher Foundation Investigator, has received the Albrecht Fleckenstein Memorial Award for Distinguished Achievement in Basic Research, was recipient of the Albert Nelson Marquis Lifetime Achievement Award, was elected as an America’s Health Insurance Plans (AHIP) Executive Leadership Fellow, a senior executive at the Harvard T.H. Chan School of Public Health, and his highly cited work has received the distinction of "High Impact Research and Potential Public Health Benefit" by the National Institutes of Health. He serves as the Founding Editor-in-Chief, Editor-in-Chief, or on the Editorial Advisory Board of numerous international journals, holds several patents, has authored and edited multiple books, has over 400 publications, is the recipient of the outstanding investigator and teaching awards, and has been elected to America's Top Physicians and The Best of U.S. Physicians.
  
  
  
  
  
  

Membership

Member American Academy Neurology, New York Academy Sciences, Association for Research in Nervous and Mental Diseases, American Neurological Association (elected), Society Neuroscience, American Heart Association, FAHA, Invited Elected Member, British Pharmacological Society, Alzheimer's Society UK, Diabetes Foundation UK, Research Council Hong Kong, Research Council Spain, Alzheimer's Research Trust, UK, Netherlands Organization Sci Research, Dutch Arthritis Foundation, Canadian Institutes of Health Research, Austrian Science Funds, International Academy of Cardiology Executive and Scientific Committee

Connections

Father:

Charles Maiese

Mother:

Margaret (Fioretti) Maiese